Indirect Transfer to Catheterization Laboratory for ST Elevation Myocardial Infarction Is Associated With Mortality Independent of System Delays: Insights From the France-PCI Registry.
Pre-hospital
ST-elevation myocardial infarction
mortality
percutaneous coronary intervention
system delays
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
10
2021
accepted:
09
02
2022
entrez:
1
4
2022
pubmed:
2
4
2022
medline:
2
4
2022
Statut:
epublish
Résumé
First medical contact (FMC)-to-balloon time is associated with outcome of ST-elevation myocardial infarction (STEMI). We assessed the impact on mortality and the determinants of indirect vs. direct transfer to the cardiac catheterization laboratory (CCL). We analyzed data from 2,206 STEMI patients consecutively included in a prospective multiregional percutaneous coronary intervention (PCI) registry. The primary endpoint was 1-year mortality. The impact of indirect admission to CCL on mortality was assessed using Cox models adjusted on FMC-to-balloon time and covariables unequally distributed between groups. A multivariable logistic regression model assessed determinants of indirect transfer. A total of 359 (16.3%) and 1847 (83.7%) were indirectly and directly admitted for PCI. Indirect admission was associated with higher risk features, different FMCs and suboptimal pre-PCI antithrombotic therapy.At 1-year follow-up, 51 (14.6%) and 137 (7.7%) were dead in the indirect and direct admission groups, respectively (adjusted-HR 1.73; 95% CI 1.22-2.45). The association of indirect admission with mortality was independent of pre-FMC and FMC characteristics. Older age, paramedics- and private physician-FMCs were independent determinants of indirect admission (adjusted-HRs 1.02 per year, 95% CI 1.003-1.03; 5.94, 95% CI 5.94 3.89-9.01; 3.41; 95% CI 1.86-6.2, respectively). Our study showed that, indirect admission to PCI for STEMI is associated with 1-year mortality independent of FMC to balloon time and should be considered as an indicator of quality of care. Indirect admission is associated with higher-risk features and suboptimal antithrombotic therapy. Older age, paramedics-FMC and self-presentation to a private physician were independently associated with indirect admission. Our study, supports population education especially targeting elderly, more adequately dispatched FMC and improved pre-CCL management.
Sections du résumé
Background
UNASSIGNED
First medical contact (FMC)-to-balloon time is associated with outcome of ST-elevation myocardial infarction (STEMI). We assessed the impact on mortality and the determinants of indirect vs. direct transfer to the cardiac catheterization laboratory (CCL).
Methods
UNASSIGNED
We analyzed data from 2,206 STEMI patients consecutively included in a prospective multiregional percutaneous coronary intervention (PCI) registry. The primary endpoint was 1-year mortality. The impact of indirect admission to CCL on mortality was assessed using Cox models adjusted on FMC-to-balloon time and covariables unequally distributed between groups. A multivariable logistic regression model assessed determinants of indirect transfer.
Results
UNASSIGNED
A total of 359 (16.3%) and 1847 (83.7%) were indirectly and directly admitted for PCI. Indirect admission was associated with higher risk features, different FMCs and suboptimal pre-PCI antithrombotic therapy.At 1-year follow-up, 51 (14.6%) and 137 (7.7%) were dead in the indirect and direct admission groups, respectively (adjusted-HR 1.73; 95% CI 1.22-2.45). The association of indirect admission with mortality was independent of pre-FMC and FMC characteristics. Older age, paramedics- and private physician-FMCs were independent determinants of indirect admission (adjusted-HRs 1.02 per year, 95% CI 1.003-1.03; 5.94, 95% CI 5.94 3.89-9.01; 3.41; 95% CI 1.86-6.2, respectively).
Conclusions
UNASSIGNED
Our study showed that, indirect admission to PCI for STEMI is associated with 1-year mortality independent of FMC to balloon time and should be considered as an indicator of quality of care. Indirect admission is associated with higher-risk features and suboptimal antithrombotic therapy. Older age, paramedics-FMC and self-presentation to a private physician were independently associated with indirect admission. Our study, supports population education especially targeting elderly, more adequately dispatched FMC and improved pre-CCL management.
Identifiants
pubmed: 35360033
doi: 10.3389/fcvm.2022.793067
pmc: PMC8962625
doi:
Types de publication
Journal Article
Langues
eng
Pagination
793067Informations de copyright
Copyright © 2022 Beygui, Roule, Ivanes, Dechery, Bizeau, Roussel, Dequenne, Arnould, Combaret, Collet, Commeau, Cayla, Montalescot, Benamer, Motreff, Angoulvant, Marcollet, Chassaing, Blanchart, Koning and Rangé.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):254-261
pubmed: 26888787
N Engl J Med. 2013 Sep 5;369(10):901-9
pubmed: 24004117
J Am Heart Assoc. 2019 May 21;8(10):e012161
pubmed: 31092091
Am J Emerg Med. 2013 Jun;31(6):922-7
pubmed: 23623235
N Engl J Med. 2014 Sep 11;371(11):1016-27
pubmed: 25175921
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Circulation. 2007 May 1;115(17):2344-51
pubmed: 17470709
Rev Epidemiol Sante Publique. 2018 May;66(3):209-216
pubmed: 29685699
Circulation. 2004 Mar 16;109(10):1223-5
pubmed: 15007008
Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):958-965
pubmed: 31475563
Circulation. 2004 Mar 2;109(8):958-61
pubmed: 14981008
Coron Artery Dis. 2018 Aug;29(5):373-377
pubmed: 29406393
Ann Intern Med. 2011 Sep 20;155(6):361-7
pubmed: 21930853
JAMA. 2004 Jun 9;291(22):2727-33
pubmed: 15187054
Lancet. 2018 Sep 8;392(10150):835-848
pubmed: 30153988
Heart. 2007 Dec;93(12):1577-83
pubmed: 17237125
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
BMJ. 2014 Oct 24;349:g6269
pubmed: 25954988
Rev Port Cardiol (Engl Ed). 2019 Sep;38(9):621-631
pubmed: 31784297
J Am Coll Cardiol. 2002 Jun 5;39(11):1733-7
pubmed: 12039484
EuroIntervention. 2018 May 20;14(1):78-85
pubmed: 29469030
JAMA. 2012 Dec 19;308(23):2507-16
pubmed: 23287889
Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(1_suppl):59-81
pubmed: 26315695
J Am Coll Cardiol. 2009 Dec 1;54(23):2145-53
pubmed: 19942086
Eur Heart J. 2004 Jun;25(12):1009-13
pubmed: 15191770
EuroIntervention. 2017 May 15;13(1):69-77
pubmed: 28134127
Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):948-957
pubmed: 32193943